Rob Stein Rob Stein is a Correspondent and Senior Editor on NPR's Science Desk.
Rob Stein, photographed for NPR, 22 January 2020, in Washington DC.
Stories By

Rob Stein

Mike Morgan/NPR
Rob Stein, photographed for NPR, 22 January 2020, in Washington DC.
Mike Morgan/NPR

Rob Stein

Correspondent and Senior Editor, Science Desk

Rob Stein is a correspondent and senior editor on NPR's science desk.

An award-winning science journalist with more than 30 years of experience, Stein mostly covers health and medicine. He tends to focus on stories that illustrate the intersection of science, health, politics, social trends, ethics, and federal science policy. He tracks genetics, stem cells, cancer research, women's health issues, and other science, medical, and health policy news.

Before NPR, Stein worked at The Washington Post for 16 years, first as the newspaper's science editor and then as a national health reporter. Earlier in his career, Stein spent about four years as an editor at NPR's science desk. Before that, he was a science reporter for United Press International (UPI) in Boston and the science editor of the international wire service in Washington.

Stein's work has been honored by many organizations, including the National Academy of Sciences, the American Association for the Advancement of Science, the American Association for Cancer Research, and the Association of Health Care Journalists. He was twice part of NPR teams that won Peabody Awards.

Stein frequently represents NPR, speaking at universities, international meetings and other venues, including the University of Cambridge in Britain, the World Conference of Science Journalists in South Korea, and the Aspen Institute in Washington, DC.

Stein is a graduate of the University of Massachusetts, Amherst. He completed a journalism fellowship at the Harvard School of Public Health, a program in science and religion at the University of Cambridge, and a summer science writer's workshop at the Marine Biological Laboratory in Woods Hole, Mass.

Story Archive

FDA officials authorize Moderna and J&J COVID vaccine boosters

  • Download
  • <iframe src="https://www.npr.org/player/embed/1047891566/1047891567" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

If You're Vaccinated, You Can Visit The US From Abroad In November

  • Download
  • <iframe src="https://www.npr.org/player/embed/1047105940/1047110639" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

The availability of COVID-19 boosters may soon expand dramatically

  • Download
  • <iframe src="https://www.npr.org/player/embed/1046952416/1046952417" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

People who got the Moderna vaccine may soon be eligible for COVID boosters

  • Download
  • <iframe src="https://www.npr.org/player/embed/1046279371/1046279372" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

NIH study of COVID-19 vaccine boosters suggests Moderna or Pfizer works best

  • Download
  • <iframe src="https://www.npr.org/player/embed/1045904225/1045904226" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

A study by the National Institutes of Health this week suggests people who got the J&J vaccine as their initial vaccination against the coronavirus may get their best protection from choosing an mRNA vaccine as the booster. Francine Orr/Los Angeles Times/Getty Images hide caption

toggle caption
Francine Orr/Los Angeles Times/Getty Images

A study of COVID vaccine boosters suggests Moderna or Pfizer works best

  • Download
  • <iframe src="https://www.npr.org/player/embed/1045485935/1045747534" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

The FDA may authorize more booster shots and is assessing a pill to treat COVID-19

  • Download
  • <iframe src="https://www.npr.org/player/embed/1045380505/1045380512" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Moderna and Johnson & Johnson release documents about COVID vaccine boosters

  • Download
  • <iframe src="https://www.npr.org/player/embed/1045260363/1045279195" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Gene-Editing Experiment Improves Sight In Patients With Impaired Vision

  • Download
  • <iframe src="https://www.npr.org/player/embed/1041443154/1041468398" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Carlene Knight, who has a congenital eye disorder, volunteered to let doctors edit the genes in her retina using CRISPR. Franny White/OHSU hide caption

toggle caption
Franny White/OHSU

A Gene-Editing Experiment Let These Patients With Vision Loss See Color Again

  • Download
  • <iframe src="https://www.npr.org/player/embed/1040879179/1041625426" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Winter Could Usher In Some Normalcy If Delta Surge Projections Are Correct

  • Download
  • <iframe src="https://www.npr.org/player/embed/1040550731/1040550732" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

CDC Director Walensky Overrules Advisers On Boosters For At-Risk Workers

  • Download
  • <iframe src="https://www.npr.org/player/embed/1040353433/1040353434" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

The pandemic appears to have peaked or be on the verge of peaking, with cases projected to slowly decline this fall and winter. As recently as Sept. 8, people were waiting at COVID-19 testing site in Kentucky, where over 4,000 new cases were confirmed that day. Jeffrey Dean/Bloomberg via Getty Images hide caption

toggle caption
Jeffrey Dean/Bloomberg via Getty Images

Is The Worst Over? Models Predict A Steady Decline In COVID Cases Through March

  • Download
  • <iframe src="https://www.npr.org/player/embed/1039272244/1039565571" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Johnson & Johnson Says Booster Shot Makes Their COVID Vaccine More Effective

  • Download
  • <iframe src="https://www.npr.org/player/embed/1039393888/1039393889" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript